X-Chem is a biotechnology company that specializes in the generation of small molecule therapeutics. Its drug discovery engine is based on a library generated by iterative combinatorial synthesis of small molecules tethered to DNA tags that record the synthetic history of the small molecule. The company focuses on protein interactions, antibacterial targets, ubiquitin ligases, epigenetic targets, and G-protein-coupled receptors (GPCRs).